BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2464453)

  • 1. [A study on catecholamine metabolites in CSF in a patient with progressive dystonia with marked diurnal fluctuation].
    Maekawa N; Hashimoto T; Sasaki M; Oishi T; Tsuji S
    Rinsho Shinkeigaku; 1988 Oct; 28(10):1206-8. PubMed ID: 2464453
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive dystonia with marked diurnal fluctuation.
    Ouvrier RA
    Ann Neurol; 1978 Nov; 4(5):412-17. PubMed ID: 570014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5 cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF].
    Kumamoto I; Nomoto M; Yoshidome H; Osame M; Igata A
    Rinsho Shinkeigaku; 1984 Jul; 24(7):697-702. PubMed ID: 6541987
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
    Willemse J; van Nieuwenhuizen O; Gooskens RH; Westenberg HG
    Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive dystonia with marked diurnal fluctuation.
    Satishchandra P; Mullati N; Suresh TG
    J Assoc Physicians India; 1992 Jan; 40(1):55-6. PubMed ID: 1634470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia with marked diurnal variation associated with biopterin deficiency.
    Fink JK; Barton N; Cohen W; Lovenberg W; Burns RS; Hallett M
    Neurology; 1988 May; 38(5):707-11. PubMed ID: 2452381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
    Jankovic J; Caskey TC; Stout JT; Butler IJ
    Ann Neurol; 1988 May; 23(5):466-9. PubMed ID: 2455472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia.
    Wolfson LI; Sharpless NS; Thal LJ
    Adv Neurol; 1988; 50():177-81. PubMed ID: 2456674
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetic study of catecholamine metabolism in hereditary progressive dystonia.
    de Jong AP; Haan EA; Manson JI; Wise GA; Ouvrier RA; Wadman SK
    Neuropediatrics; 1989 Feb; 20(1):3-11. PubMed ID: 2716962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
    Abeling NG; Duran M; Bakker HD; Stroomer L; Thöny B; Blau N; Booij J; Poll-The BT
    Mol Genet Metab; 2006; 89(1-2):116-20. PubMed ID: 16650784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q.
    Tanaka H; Endo K; Tsuji S; Nygaard TG; Weeks DE; Nomura Y; Segawa M
    Ann Neurol; 1995 Mar; 37(3):405-8. PubMed ID: 7695242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation.
    Fink JK; Ravin P; Argoff CE; Levine RA; Brady RO; Hallett M; Barton NW
    Neurology; 1989 Oct; 39(10):1393-5. PubMed ID: 2477772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary progressive dystonia with marked diurnal fluctuation: clinicopathophysiological identification in reference to juvenile Parkinson's disease.
    Segawa M; Nomura Y; Kase M
    Adv Neurol; 1987; 45():227-34. PubMed ID: 3825694
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopa responsive dystonia with diurnal fluctuation (Segawa's syndrome).
    Ong LC; Tang SF; Lal TR
    Med J Malaysia; 1994 Jun; 49(2):176-8. PubMed ID: 8090100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary progressive levodopa sensible: Segawa's syndrome].
    Grippo J; La Fuente A; Corral SM; Grippo T
    Rev Neurol; 2002 May 16-31; 34(10):933-6. PubMed ID: 12134322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CSF somatostatin and amine metabolites in spinocerebellar degenerations].
    Shimoda K; Hikasa C; Nishikawa S; Takahashi K
    Rinsho Shinkeigaku; 1987 Aug; 27(8):996-1001. PubMed ID: 2446812
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
    Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
    Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary progressive dystonia with marked diurnal fluctuation--consideration on its pathophysiology based on the characteristics of clinical and polysomnographical findings.
    Segawa M; Nomura Y; Tanaka S; Hakamada S; Nagata E; Soda M; Kase M
    Adv Neurol; 1988; 50():367-76. PubMed ID: 3041759
    [No Abstract]   [Full Text] [Related]  

  • 20. Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Adv Neurol; 1988; 50():193-201. PubMed ID: 2456675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.